HEPSIN inhibits cell growth/invasion in prostate cancer cells.
暂无分享,去创建一个
[1] T. Guthrie,et al. Prostate cancer. , 2020, American family physician.
[2] K. Kurachi,et al. A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. , 1988, Biochemistry.
[3] K. Kurachi,et al. Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. , 1991, The Journal of biological chemistry.
[4] K. Kurachi,et al. Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Brooks,et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[6] P. Weijerman,et al. Characterization of adult human prostatic epithelial-cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin-defective sv40-genome. , 1994, International journal of oncology.
[7] M. Garnick,et al. The dilemmas of prostate cancer. , 1994, Scientific American.
[8] M. Webber,et al. Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] W. Kisiel,et al. Hepsin, a Putative Membrane-associated Serine Protease, Activates Human Factor VII and Initiates a Pathway of Blood Coagulation on the Cell Surface Leading to Thrombin Formation (*) , 1995, The Journal of Biological Chemistry.
[10] J. Rhim,et al. Radiation-induced Neoplastic Transformation of Human Prostate Epithelial Cells' , 2006 .
[11] M. Webber,et al. Malignant transformation of human prostate epithelial cells by N-nitroso-N-methylurea. , 1997, Cancer research.
[12] K. Kinzler,et al. The Genetic Basis of Human Cancer , 1997 .
[13] K. Shigemasa,et al. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. , 1997, Cancer research.
[14] M. Halks-Miller,et al. Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. , 1998, The Journal of clinical investigation.
[15] W. Kisiel,et al. Expression of the Factor VII Activating Protease, Hepsin, in situ in Renal Cell Carcinoma , 1998, Thrombosis and Haemostasis.
[16] M K Brawer. Prostate-specific antigen. , 2000, Seminars in surgical oncology.
[17] H. Scher,et al. Clinical states in prostate cancer: toward a dynamic model of disease progression. , 2000, Urology.
[18] Shu-Wha Lin,et al. Mice Deficient in Hepsin, a Serine Protease, Exhibit Normal Embryogenesis and Unchanged Hepatocyte Regeneration Ability , 2000, Thrombosis and Haemostasis.
[19] D. Kelsell,et al. Spotting prostate cancer. , 2001, Trends in molecular medicine.
[20] Jeffrey A. Magee,et al. Expression profiling reveals hepsin overexpression in prostate cancer. , 2001, Cancer research.
[21] J. Welsh,et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.
[22] Q. Wu. Gene targeting in hemostasis. Hepsin. , 2001, Frontiers in bioscience : a journal and virtual library.
[23] S. Dhanasekaran,et al. Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.
[24] M. Bittner,et al. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. , 2001, Cancer research.
[25] N. Greenberg,et al. Down‐regulation of prostasin serine protease: A potential invasion suppressor in prostate cancer , 2001, The Prostate.
[26] T. Stamey,et al. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. , 2001, The Journal of urology.
[27] Debashis Ghosh,et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. , 2002, JAMA.
[28] E. Gelmann,et al. Molecular biology of the androgen receptor. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Matthias Kretzler,et al. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. , 2002, The American journal of pathology.
[30] J. Trent,et al. α-methylacyl-CoA racemase: A new molecular marker for prostate cancer , 2002 .
[31] J. Rhim,et al. Cadmium-induced neoplastic transformation of human prostate epithelial cells. , 2002, International journal of oncology.
[32] J. Moul,et al. Molecular markers in prostate cancer: the role in preoperative staging. , 2002, Clinical prostate cancer.
[33] Ahmedin Jemal,et al. Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.
[34] V. Srikantan,et al. Molecular Dissection of the Prostate Cancer Genome , 2003 .
[35] L. Magnelli,et al. Multiple pathways of cell invasion are regulated by multiple families of serine proteases , 2004, Clinical & Experimental Metastasis.